Evidence map›Paper›PMID 42714841›Full record

ArticleFEMS microbiology letters2026

Conference report: The Third Bacterial Genome Sequencing Pan-European Network conference.

Nina Liuta, Claire Bertelli, Kira Waagner Birkeland, Sofia Brunet, David Eyre, Christian G Giske, Gilbert Greub, Yukino Gütlin, Andre Kahles, Maria Lind Karlberg and 18 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in FEMS microbiology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Nina LiutaInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0002-7159-3750
Claire BertelliInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0003-0550-8981
Kira Waagner BirkelandDepartment of Microbiology, Innlandet Hospital Trust, 2381 Brumunddal, Norway.ORCID 0009-0002-4798-9322
Sofia BrunetDepartment of Clinical Microbiology, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.ORCID 0000-0002-9755-0089
David EyreBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7LF, United Kingdom.ORCID 0000-0001-5095-6367
Christian G GiskeKarolinska Institute, 171 77 Stockholm, Sweden.ORCID 0000-0003-4327-6122
Gilbert GreubInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0001-9529-3317
Yukino GütlinInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0003-2933-2001
Andre KahlesEidgenössische Technische Hochschule Zürich, 8092 Zürich, Switzerland.ORCID 0000-0002-3411-0692
Maria Lind KarlbergDepartment of Microbiology, Public Health Agency of Sweden, 171 82 Solna, Sweden.ORCID 0000-0002-1788-2295
Adriána LiptákováMinistry of Health, 837 52 Bratislava, Slovakia.ORCID 0000-0002-1677-0590
David NestorÖrebro University, 701 82 Örebro, Sweden.ORCID 0000-0002-8904-600X
Oliver NolteInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0002-1761-0812
Alban RametteInstitute for Infectious Diseases, University of Bern, 3001 Bern, Switzerland.ORCID 0000-0002-3437-4639
Derren ReadyUK Health Security Agency (South West), Bristol BS1 6EH, United Kingdom.ORCID 0000-0003-4894-3641
Daniel Rodriguez RozoInstitute of Microbiology, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0009-0005-1701-653X
Janis RogenmoserInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0009-0009-6586-8664
Tim RoloffInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0003-3435-4723
Ashley RooneyInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0002-2874-8120
Jacques SchrenzelClinical Microbiology, University Hospital Geneva, 1211 Geneva, Switzerland.ORCID 0000-0001-5464-7764
Helena M B Seth-SmithInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0002-6082-5114
Martin SundqvistDepartment of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, 701 82 Örebro, Sweden.ORCID 0009-0003-7928-9555
Fanny WegnerInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0003-4348-5872
Hege Vangstein AamotDepartment of Microbiology and Infection Control, Akershus University Hospital, 1478 Lørenskog, Norway.ORCID 0000-0002-3176-8560
Mario RamirezFaculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal.ORCID 0000-0002-4084-6233
Paula MöllingDepartment of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, 701 82 Örebro, Sweden.ORCID 0009-0000-1143-9105
Adrian EgliInstitute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0002-3564-8603
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Genomic and Molecular Diagnostics (ESGMD)

Funding

ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD)Örebro University HospitalUniversity of Zurich
6 · The paper itself

Abstract

The third Bacterial Genome Sequencing Pan-European Network conference, held in Engelberg, Switzerland (12-15 January 2026), brought together experts from six European countries to discuss the implementation of bacterial genome sequencing in clinical microbiology and public health. Key themes included regulatory frameworks (In Vitro Diagnostic Regulation, General Data Protection Regulation), standardization, quality control, data sharing, economic evaluation, and the integration of artificial intelligence and long-read sequencing into diagnostic workflows. Across presentations, panel discussions, and workshops, participants emphasized that successful implementation of genome sequencing requires more than technical capacity: it depends on robust validation, sustainable funding, interoperable data standards, ethical governance, and interdisciplinary collaboration. The meeting highlighted that sequencing should remain question-driven and clinically meaningful, balancing cost, turnaround time, and public health impact. Overall, the conference reinforced the need for coordinated European efforts to advance responsible, standardized, and sustainable genomic surveillance and diagnostics.

Indexed as

BacteriaGenome, BacterialWhole Genome SequencingEuropeHumansPublic Healthbacterial genome sequencingcost-effectivenessdata sharingpublic health surveillancequality assurancestandardization

Identifiers

PMID42714841
PMCPMC13602410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.